Ensuring equity with pre-clinical planning for chlamydia vaccines.
Journal Information
Full Title: NPJ Vaccines
Abbreviation: NPJ Vaccines
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests The authors declare the following competing interests: A.L.C. and K.M.F. are inventors on a patent application describing a vaccine against Chlamydia trachomatis. Inventors: Frietze KM and Collar AL. “Bacteriophage virus-like particle vaccines for Chlamydia trachomatis adhesion factors and proteins involved in pathogenesis”. PCT/US22/255542. Filed April 20, 2022."
Funding Disclosure
Evidence found in paper:
"This work was supported by NIH/NIAID F30 AI156995 to A.L.C., NIH/NIAID T32 AI007538 to A.N.J., and NIH/NIAID R01 AI148836 to K.M.F."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025